company background image
RDTC.F logo

Rapid Dose Therapeutics OTCPK:RDTC.F Stock Report

Last Price

US$0.17

Market Cap

US$19.7m

7D

0%

1Y

n/a

Updated

23 Dec, 2024

Data

Company Financials

Rapid Dose Therapeutics Corp.

OTCPK:RDTC.F Stock Report

Market Cap: US$19.7m

RDTC.F Stock Overview

A life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. More details

RDTC.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Rapid Dose Therapeutics Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Rapid Dose Therapeutics
Historical stock prices
Current Share PriceCA$0.17
52 Week HighCA$0.39
52 Week LowCA$0.0029
Beta0.66
1 Month Change-6.34%
3 Month Changen/a
1 Year Changen/a
3 Year Change-56.24%
5 Year Change-45.28%
Change since IPO-54.67%

Recent News & Updates

Recent updates

Shareholder Returns

RDTC.FUS Life SciencesUS Market
7D0%-2.1%-2.7%
1Yn/a-5.5%23.4%

Return vs Industry: Insufficient data to determine how RDTC.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how RDTC.F performed against the US Market.

Price Volatility

Is RDTC.F's price volatile compared to industry and market?
RDTC.F volatility
RDTC.F Average Weekly Movementn/a
Life Sciences Industry Average Movement9.1%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: RDTC.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RDTC.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aMark Upsdellrapid-dose.com

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients.

Rapid Dose Therapeutics Corp. Fundamentals Summary

How do Rapid Dose Therapeutics's earnings and revenue compare to its market cap?
RDTC.F fundamental statistics
Market capUS$19.66m
Earnings (TTM)-US$3.73m
Revenue (TTM)US$933.42k

21.1x

P/S Ratio

-5.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RDTC.F income statement (TTM)
RevenueCA$1.34m
Cost of RevenueCA$554.82k
Gross ProfitCA$786.56k
Other ExpensesCA$6.15m
Earnings-CA$5.37m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.042
Gross Margin58.64%
Net Profit Margin-400.10%
Debt/Equity Ratio-69.4%

How did RDTC.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:29
End of Day Share Price 2024/12/11 00:00
Earnings2024/08/31
Annual Earnings2024/02/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rapid Dose Therapeutics Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter-Thilo HaslerSphene Capital GmbH